Statements, Letters, and Regulatory Comments

Statements, Letters, and Regulatory Comments

By educating elected officials and other government decision-makers on the needs of the cystic fibrosis community, the Cystic Fibrosis Foundation works to shape public policy to help our efforts to cure CF and provide all people with CF the opportunity to live full, healthy lives. Below find a listing of our state and federal statements, letters, and regulatory comments.

Statements, letters, and regulatory comments issued before July 2023 can be found in our archive.

Drug Pricing and Access | Prior Authorization CF Foundation Supports Illinois' Efforts to Cap Copays for Inhalers and Streamline Prior Authorization Requirements

In a letter to the Illinois House Health Care Availability & Accessibility Committee and the Illinois House Insurance Committee, the Cystic Fibrosis Foundation expressed support for two bills — HB 4504, which would limit copays for prescription inhalers, and HB 5051, which would prohibit prior authorization on long-term prescriptions.

March 12, 2024
Drug Pricing and Access CF Foundation Comments on Proposed Legislation to Create a Prescription Drug Affordability Board in Illinois

In a letter to the Illinois General Assembly, the CF Foundation provides feedback on HB 4472 which would establish an affordability board with the goal to improve access to and affordability of care for Illinoisans.

Jan. 25, 2024